December 22, 2021 Comments Off on New patent for Abbvie Inc drug MAVYRET Posted in: Patent Added Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…
The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWat…
December 21, 2021 Comments Off on New patent for Abbvie Inc drug RINVOQ Posted in: Patent Added Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Abbvie Inc drug RINVOQ appeared first on DrugPatentWatch -…